Our data indicate, however, that elevated plasma IGFBP-2 levels after postoperative radiotherapy plus chemotherapy in elderly GBM patients is a predictor of poor prognosis, and that strategies to reduce plasma IGFBP-2 levels may be a suitable treatment approach in GBM patients. Here, IGFBP2 is linked to glioblastoma.